Compared to classical gastroprotective peptides such as sucralfate or proton pump inhibitors (PPIs), it acts via a completely different pathway: restoration of mucosal microcirculation rather than acid reduction or formation of a mechanical protective layer
GLP-1 has been proven to be a useful adjuvant therapy in type-2 diabetes mellitus, metabolic syndrome, and hyperglycemia
Effect on the Gastrointestinal Absorption of Drugs from Different Classes in the Biopharmaceutics Classification System, When Treating with Liraglutide
Peptides signal proteins that boost collagen production, improve skin firmness and resilience, and help retain moisture for a plumper, smoother complexion over time
The GIP component of the blend has been shown in murine models to improve the buffering capacity of adipose tissue, reducing circulating triglycerides and preventing ectopic fat accumulation in the liver